An Engineered Maturation Cleavage Provides a Recombinant Mimic of Foot-and-Mouth Disease Virus Capsid Assembly-Disassembly by Newman, J et al.
life
Article
An Engineered Maturation Cleavage Provides a Recombinant
Mimic of Foot-and-Mouth Disease Virus Capsid
Assembly-Disassembly
Joseph Newman 1 , David J. Rowlands 2 and Tobias J. Tuthill 1,*


Citation: Newman, J.; Rowlands,
D.J.; Tuthill, T.J. An Engineered
Maturation Cleavage Provides a
Recombinant Mimic of
Foot-and-Mouth Disease Virus
Capsid Assembly-Disassembly. Life
2021, 11, 500. https://doi.org/
10.3390/life11060500
Academic Editors: Adam Taylor and
Marko Noerenberg
Received: 28 April 2021
Accepted: 26 May 2021
Published: 29 May 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 The Pirbright Institute, Pirbright GU24 0NF, UK; joseph.newman@pirbright.ac.uk
2 School of Molecular and Cellular Biology & Astbury Centre for Structural Molecular Biology, Faculty of
Biological Sciences, University of Leeds, Leeds LS2 9JT, UK; d.j.rowlands@leeds.ac.uk
* Correspondence: toby.tuthill@pirbright.ac.uk
Abstract: Picornavirus capsids are assembled from 60 copies of a capsid precursor via a pentameric
assembly intermediate or ‘pentamer’. Upon completion of virion assembly, a maturation event
induces a final cleavage of the capsid precursor to create the capsid protein VP4, which is essential
for capsid stability and entry into new cells. For the picornavirus foot-and-mouth disease virus
(FMDV), intact capsids are temperature and acid-labile and can disassemble into pentamers. During
disassembly, capsid protein VP4 is lost, presumably altering the structure and properties of the
resulting pentamers. The purpose of this study was to compare the characteristics of recombinant
“assembly” and “disassembly” pentamers. We generated recombinant versions of these different
pentamers containing an engineered cleavage site to mimic the maturation cleavage. We compared
the sedimentation and antigenic characteristics of these pentamers using sucrose density gradients
and reactivity with an antibody panel. Pentamers mimicking the assembly pathway sedimented
faster than those on the disassembly pathway suggesting that for FMDV, in common with other
picornaviruses, assembly pentamers sediment at 14S whereas only pentamers on the disassembly
pathway sediment at 12S. The reactivity with anti-VP4 antibodies was reduced for the 12S pentamers,
consistent with the predicted loss of VP4. Reactivity with other antibodies was similar for both
pentamers suggesting that major antigenic features may be preserved between the VP4 containing
assembly pentamers and the disassembly pentamers lacking VP4.
Keywords: foot-and-mouth disease virus; picornavirus; capsid assembly; antigenicity
1. Introduction
The Picornaviridae are a family of viruses with small (approximately 30 nm) non-
enveloped icosahedral capsids containing a single copy of positive sense RNA genome. The
family contains many important pathogens of humans and animals including poliovirus,
human rhinovirus and foot-and-mouth disease (FMD) virus (FMDV). The global burden
of FMD on livestock is significant and can incur large economic costs due to production
losses, trade restrictions and control strategies including vaccination [1].
The FMDV capsid assembles via multimerisation of precursor subunits which encap-
sidate a single copy of the viral RNA genome. The viral RNA is infectious and when it
enters the cytoplasm of cells, a single open reading frame (ORF) is translated into a polypro-
tein containing both structural (capsid precursor) and non-structural proteins [2]. During
translation the capsid precursor, P1-2A, is released from the polyprotein by cleavage at its
N-terminus by the viral Leader protease [3] and by a ribosomal slippage at the C-terminus
of 2A, which separates P1-2A from the downstream polyprotein [4]. The N-terminus of P1-
2A is myristoylated by a host-enzyme [5] and the viral 3C protease (3Cpro) cleaves P1-2A in
three places to generate the complex of VP0-VP3-VP1 which remains associated as a capsid
protomer [6] and multimerises into a pentameric subunit. Twelve pentamers with intact
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VP0 are thought to multimerise in a concentration dependent manner to form provirions
when in the presence of viral RNA [7] or empty capsids in the absence of RNA [8,9].
The cleavage of VP0 into VP4 and VP2, known as the “maturation cleavage” is the
final event in picornavirus morphogenesis and is thought to be catalysed by RNA during
encapsidation in poliovirus [10,11], however, empty capsids of FMDV can also contain
cleaved VP0 suggesting a different mechanism [12–14]. Upon cleavage, VP4 and VP2
remain associated with the virion as individual capsid proteins with their now free termini
participating in inter-protomer interactions [15] allowing the virus to adopt a “meta-stable”
state for the infection of new cells [16].
During entry into host cells, FMDV virions rapidly disassemble into pentamers when
the pH of endosomes becomes acidic (<pH 6.8) [17,18]. It has been proposed that the
propensity of FMDV to fall apart into pentamers under acidic pH or elevated temperatures
can be explained by the protonation of two histidine residues near the two-fold pentamer
interface causing electrostatic repulsion between two pentameric subunits in increasingly
acidic conditions [12,19,20]. Upon conversion of virions into pentamers, VP4 is lost and so
pentamers disassembled from virions consist of VP2-VP3-VP1 [18].
Conventional FMD vaccines are commonly generated by inactivation with binary
ethylenimine (BEI) and purification of virus particles. However, such preparations are
unstable over prolonged storage or when cold chains are not maintained [21,22]. This
loss of stability refers to the disassembly of virions into pentamers [23–25] and this
correlates with loss of vaccine efficacy as the disassembled pentamers are no longer
immunogenic [24,26–28]. Empty capsids lacking RNA, which form spontaneously dur-
ing infection or which can be made recombinantly, are immunogenic [24,28] but are also
unstable unless artificially stabilised [29].
The generation of native assembly pentamers is generally achieved by purifying
VP0-containing empty particles and dissociating at high pH into pentamers. This is
technically challenging and not possible for many viruses which either do not assemble
a large proportion of empty capsids or do not retain a majority of uncleaved VP0. In
this study we wished to generate and characterise recombinant FMDV capsid pentamers
mimicking “assembly” and “disassembly” pentamers where the presence of VP4 could
be controlled by an engineered cleavage site to mimic the maturation cleavage (Figure 1).
The recombinant approach we describe bypasses the technical difficulties in production of
native assembly pentamers and allows the direct comparison of pentamers which differ
only in the cleavage status of VP0. We show that recombinant pentamers with intact
VP0 (presence of VP4) have faster sedimentation than those with cleaved VP0, consistent
with 14S and 12S sedimentation phenotypes. Pentamers with cleaved VP0 had reduced
reactivity with anti-VP4 antibodies, confirming the loss of VP4 but reactivity with other
antibodies was similar for both pentamers.
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Figure 1. Assembly and disassembly of FMDV capsids and control of pentamer switching. Black 
arrows indicate pathway of normal FMDV capsid assembly and disassembly. The green arrow 
represents the pathway taken by the ‘maturation engineered’ pentamers generated in this study. 
Processing of P1-2A facilitates folding of P1-2A into an assembly competent protomer (5S) fol-
lowed by assembly of 5 protomers into a pentameric structure with 14S sedimentation containing 
intact VP0 protein. Twelve pentamers assemble into intact capsids in a concentration dependent 
manner and if viral RNA is encapsidated they form virions (146S). Low pH, heat or cell entry trig-
ger the disassembly of intact capsids into disassembly versions of pentamers (12S) containing VP2 
and lacking VP4. An introduced maturation cleavage mutation allows conversion of assembly 
pentamers directly into disassembly pentamers. Created with Biorender.com. 
2. Materials and Methods 
2.1. Generation of Plasmids 
The plasmids used in this work were generated according to standard molecular bi-
ology protocols [30]. The wild-type (wt) version of FMDV capsid precursor was expressed 
from an existing plasmid (pBG200-P1-Δ2A) [31] which encoded P1 and a truncated form 
of 2A capsid precursor from the O1 Manisa strain of FMDV.  
Overlap PCR mutagenesis was used to generate a mutant of the capsid precursor that 
had an independently cleavable VP4/VP2 junction. Two sets of primers (5’-
CTGAGGCTTCTTTAAAAGCGCTC and 5’-GGGCCCCTGGAACAGAACTTCCAGAA-
GACCGCTGAAAGCGGAAC, 5’-CTGGAAGTTCTGTTCCAGGGG-CCCAAAAC-
CGAGGAGACCACTCTTCTG and 5’-CTGTGTCTCGCCACCGTAATTCT where red ba-
ses indicate mutated primer tails), were used to generate two amplicons using KOD pol-
ymerase (Roche). These two amplicons were purified by agarose gel electrophoresis and 
gel extracted using GFX PCR DNA and gel band purification kit (GE Healthcare, Chicago, 
USA), before being added in equi-molar quantities to a second PCR reaction using only 
the flanking primers from above to generate a single amplicon which was ligated (T4 lig-
ase; NEB, Ipswich, USA) back into the pBG200-P1-Δ2A vector. The mutated sequences 
were confirmed by sequencing. 
2.2. Proteases 
Figure 1. Assembly and disassembly of FMDV capsids and control of pentamer switching. Black
arrows indicate pathway of normal FMDV capsid assembly and disassembly. Th green arrow
represents the pathway taken by the ‘maturatio e gin ered’ pentamers gen rated in this study.
Processing of P1-2A facilitates folding of P1-2A into an a sembly competent protomer (5S) followed
by assembly of 5 protomers into a pentameric structure with 14S sedimentation containing intact
VP0 protein. Twelve pentamers assemble into intact capsids in a concentration dependent manner
and if viral RNA is encapsidated they form virions (146S). Low pH, heat or cell entry trigger the
disassembly of intact capsids into disassembly versions of pentamers (12S) containing VP2 and
lacking VP4. An introduced maturation cleavage mutation allows conversion of assembly pentamers
directly into disassembly pentamers. Created with Biorender.com.
2. Materials and Methods
2.1. Generation of Plasmids
The plasmids used in this work were generated according to standard molecular
biology protocols [30]. The wild-type (wt) version of FMDV capsid precursor was expressed
from an existing plasmid (pB 200- -∆ ) [ ] ic c 1 and a truncated form of
2A capsid precursor from the O1 Manisa strain of FMDV.
Overlap PCR mutag nesis was used to generate mutant of the capsid precur-
sor that had an independ ntly cleavable VP4/VP2 junction. Two sets of primers (5′-
CTGA GC TC TAAAAGCGCTC ′- CCCTGGAACAGAACT C AGA GA
C GCTGA GCGGAAC, 5′-CTGGAAGTTCTGT C A GGG-CCCAAAA G GGAG
ACCACTCTT TG and 5′-CTGTGTCT GCCACCGTAATT T where red bases indicate mu-
tated primer tails), were used to generate two amplicons using KOD polymerase (Roche).
These two amplicon were purified by agarose gel electrophoresis and gel extracted using
GFX PCR DNA and gel band purification kit (GE He lthcare, Chicago, IL, USA), bef re
being add d in equi-molar quantities to a second PCR reaction using only the flanking
primers from above to generate a single amplicon which was ligated (T4 ligase; NEB,
Ipswich, UK) back into the pBG200-P1-∆2A vector. The mutated sequences were confirmed
by sequencing.
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2.2. Proteases
FMDV 3Cpro was expressed in E.coli from plasmids obtained from Stephen Curry at
Imperial College London [32] according to the method we have described previously [31].
Purification of 3Cpro was via a C-terminal His6 tag using immobilised metal affinity chro-
matography (HisTrap FF; GE Healthcare). The purified enzyme was dialysed (10K MWCO,
Slide-a-Lyzer; Pierce, Rockford, IL, USA) against 50 mM HEPES pH7.1, 0.2 M NaCl, 1 mM
EDTA, 1 mM β-mercaptoethanol and 5% glycerol.
Precission protease (Prepro, Novagen, Madison, WI, USA) was obtained commercially.
2.3. Cell Free Processing and Assembly
Radiolabelled capsid precursors and pentamers were generated according to a previ-
ous protocol [31]. Briefly, expression plasmids (20 ng/µL) were programmed into rabbit
reticulocyte lysates (TnT quick; Promega, Madison, WI, USA) containing 8 Bq/µL L-{35S]-
Methionine (EasyTag; Perkin Elmer, Waltham, MA, USA) according to the manufacturer’s
instructions to generate capsid precursors. These reactions were then mock treated with
PBS (without cations; Pirbright CSU, Woking, UK) or treated with 1 µM 3Cpro or 0.2 U/µL
Prepro and incubated for 1 h at 37 ◦C, or reactions were treated sequentially with each
protease for a second hour at 37 ◦C. After incubation, free radiolabel was removed from the
reaction mixtures by three rounds of dialysis (10 kDa Slide-A-Lyzer mini dialysis cassettes
pre-blocked with 1% bovine serum albumin in PBS) against 500 mL PBS.
2.4. SDS-PAGE and Fluorography
To analyse processing and assembly reactions, proteins were resolved through 12%
Tris-glycine SDS-PAGE gels (mini-protean II; Bio-rad; 37.5:1 Acrylamide/Bis acrylamide),
the gels were soaked in 1 M sodium salicylate (VWR) for 30 min, dried for one hour at
80 ◦C (DrygelSR, Hoefer, San Francisco, CA, USA), exposed to film at −80 ◦C overnight
and developed using standard photographic reagents.
2.5. SDGs
The sedimentation of capsid precursors, protomers and pentamers was analysed by
sucrose density gradients (SGDs) by the method described by a previous protocol [31].
Briefly, samples were sedimented through 5 mL 5–30% sucrose gradients (Gradient master;
Biocomp) for 6 h at 286,794× g average, at 10 ◦C in an SW55Ti rotor (Beckman Coulter,
Brea, CA, USA).
Gradients were fractionated (Piston gradient fractionator, Biocomp, Fredericton,
Canada) into 24 equal fractions which were diluted 1:5 in scintillation fluid (Optiphase
Supermix; PerkinElmer) for counting (LS6500 multipurpose scintillation counter; Beckman
Coulter).
2.6. Purifying Antibodies from Bovine Sera
To generate antibody reagents specifically reactive with VP4 and VP2, two peptides
were synthesised (Peptide Protein Research) that corresponded to the highly conserved N-
terminal 45 amino acids of FMDV VP2 (DKKTEETTLLEDRILTTRNGHTTSTTQSSVGVTYG
YATAEDFVSGKKKKKK-biotin) and VP4 (Myristic acid-GAGQSSPATGSQNQSGNTGSIIN
NYYMQQYQNSMDTQLGDNAISGKKKKKK-biotin) with lysine residues at the C-terminus
for enhanced solubility followed by biotin for purification. The peptides were bound to
StrepTrap HP columns (GE Healthcare) and unbound peptide was removed by wash-
ing. Bovine sera raised against FMDV (WRLFMD Pirbight), was clarified by low speed
centrifugation and run through the column using a peristaltic pump (EP1 Econo pump;
Bio-Rad, Hercules, CA, USA). The columns were then washed with buffers of increasing
acidity (50 mM glycine, 150 mM NaCl pH values were 6, 5, 4, 2.7 and 1.9). Each fraction
eluted from the column was neutralised with 10× neutralisation buffer (1 M Tris-HCl, pH
8; 1.5 M NaCl, 1 mM EDTA). The presence of antibody in eluted fractions was confirmed
by SDS-PAGE.
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2.7. Pentamer Immunoprecipitation
Peak gradient fractions containing radiolabelled pentamers were pooled and dialysed
(G2 3 mL 20kDa MWCO dialysis cassettes; ThermoFisher) against 1 L PBS twice to remove
sucrose. Radioactivity in each sample was counted. Samples of pentamers (approx. 105
35S counts) were mixed with an amount of antibody pre-determined to give complete
immunoprecipitation of wt pentamers. Antibody-pentamer mixtures were incubated for
two hours with shaking at room temperature. Next, 50 µL protein A magnetic beads for
guinea pig polyclonal antibodies or protein G magnetic beads (Thermo Fisher Scientific,
Waltham, MA, USA) for bovine and mouse antibodies were washed and then incubated
with the antibody-pentamer complexes with shaking for one hour at room temperature.
The complexes were washed three times with PBS-T (0.1% Tween-20; Sigma, St. Louis),
and then any immunoprecipitated protein was eluted with 50 mM glycine pH 1.9 in PBS-T.
Samples were read by scintillation counting as above and each pull down was expressed
as proportion of the input radioactivity.
3. Results
A final event in picornavirus morphogenesis is the cleavage of VP0 into VP4 and VP2
(the maturation cleavage).
Previously we have shown that a cell-free system can be used to study FMDV capsid
precursor processing and pentamer assembly [31,33] and here we have further developed
this system to analyse the effect of the maturation cleavage on pentamer properties.
3.1. An Artificial Maturation Cleavage Site Can Be Independently Processed
The amino acid sequence at the FMDV VP4/2 junction is highly conserved between
FMDV serotypes; LFGALLA/DKKTEETT (where “/” represents the protein junction; [34,35]).
We modified an existing FMDV serotype O capsid precursor expression plasmid to insert a
PreScission Protease (Prepro) cleavage site at this junction; LLEVLFQ/GPKTEET (termed
mat, for maturation mutant).
The Prepro protease is a recombinant commercial version of purified human rhinovirus
14 3Cpro. Human rhinovirus 3Cpro has fairly stringent requirements for Q/G at P1/P1′ sites
of cleavage junctions whereas FMDV 3Cpro is more tolerant in its amino acid requirements
at cleavage junctions [36] due to an extended β-ribbon structure in the substrate binding
cleft [37].
To confirm that the engineered maturation cleavage site at the VP4/2 boundary was
accessible to Prepro, and that processing of the FMDV 3Cpro cleavage sites and the matu-
ration site could be controlled independently, wt (Figure 2, upper panel) or mat (Figure 2,
lower panel) capsid precursors were expressed and cleaved by each protease individually
or by both proteases sequentially. In uncleaved wt samples, a band corresponding to the
expected size of P1-2A was observed (Figure 2, upper panel, Lane 1), which was cleaved by
FMDV 3Cpro to produce bands corresponding to the expected sizes of capsid proteins VP0,
VP1 and VP3 (Figure 2 upper panel, Lane 2). No further changes were observed following
subsequent or prior treatment with Prepro (Figure 2, upper panel, Lanes 3–5). In contrast,
VP0 from the mat P1-2A was replaced by VP2 as expected from the additional cleavage
event (Figure 2, lower panel, Lanes 3 and 5). VP2 and VP3 co-migrate as a single band of
slightly larger apparent molecular weight than VP3 alone. Pretreatment of wt with Prepro
did not affect the precursor or product profiles but pretreatment of mat P1-2A produced a
band corresponding to VP2-VP3-VP1 (Figure 2, Lane 4) as expected. Subsequent treatment
with 3Cpro produced the same banding pattern as when the two proteases were used in the
alternative order (Figure 2, lower panel, Lane 5). The relative intensities of the bands seen
in the autoradiographs reflect the different methionine contents of the O1 Manisa capsid
proteins—VP1,VP2, VP3, VP0, (2, 4, 4 and 6 methionine residues respectively). VP4 (7kDa)
was too small to be resolved on these gels.
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right of the gel images and the positions of molecular weight markers are indicated to the left. 
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tively). However, following additional treatment with Prepro, the sedimentation rates of 
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Figure 2. FMDV capsid precu sor mat mutant can be cleaved by Prepro independently of 3Cpro
processing. Cell free expression reactions of wt (top panel) r at (bottom panel) were either
unprocessed (Lane 1), processed with 3Cpro (Lane 2) and then Prepr (Lane 3), or processed with
Prepro (Lane 4) and then 3Cpro (Lane 5) as indicated above the gel image for one hour at 37 ◦C.
Arrows indicate sequential treatment with both proteases. Samples were resolved by SDS-PAGE and
visualised by fluorography. The predicted sizes of capsid proteins and precursors are identified to
the right of the gel images and the positions of molecular weight markers are indicated to the left.
These results demonstrated that Prepro cleaved specifically at the introduced site in
the capsid precursor P1-2A independently of FMDV 3Cpro.
3.2. Maturation Site-Cleaved Pentamers Have a Slower Sedimentation Coefficient Than
Asse bly Pentamers
We have shown previously that incubation of recombinant P1-2A with 3Cpro resulted
in the assembly of pentamers [31,33]. We now wished to use the engin ered maturation
site to analyse th effect of VP0 cleavage on sedimentation of protomers and assembled
pentamers. P1-2A precursors (wt or mat) were treated with proteases or mock treated and
the sedimentation of the resulting assembly products was determined by centrifugation
through sucrose density gradients.
Mock treated wt P1-2A sedimented as a single peak at the expected position for capsid
precursor (5S) (Figure 3; upper panel blue trace) and treatment with 3Cpro roduced two
peaks sedimenting at the expected positions for 5S protomers and assembled pentamers
(Figure 3; upper panel red trace). Treatment of mat P1-2A with 3Cpro alone produced
similar results as with wt P1-2A (Figure 3; lower panel blue and red traces respectively).
However, following additional treatment with Prepro, the sedimentation rates of both the
protomer and pentamer peaks were reduced (Figure 3; lower panel orange trace). In this
case, the pentamer peak sedimented at a position identical to disassembly pentamers
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derived by denaturation of virus particles, which have a sedimentation coefficient of
12S [31]. Sedimentation of the protomer was similarly reduced. Interestingly, initial
treatment with Prepro followed by 3Cpro resulted again in a slower sedimenting protomer
but in this case no peak corresponding to pentamers was seen (Figure 2; lower panel, black
trace), suggesting that the presence of uncleaved VP0 is essential for higher order assembly
to occur.
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treatment with 3Cpro then Prepro (orange) or Prepro then 3Cpro (black). Gradient profiles are single data points, representative
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These results demonstrated that the cleavage of VP0 slightly reduced the sedimenta-
tion coefficients of both protomer and pentamer particles, suggesting that the multimeric
state of these pentamers was still intact and that VP0 cleavage only minimally altered
Life 2021, 11, 500 8 of 12
the structure. The sedimentation coefficient of wt pentamers was estimated to be 14S,
consistent with the assembly competent pentamers of other picornaviruses [2], whereas
cleavage of VP0 reduced this value to 12S, the same as seen for pentamers released from
virus particles by thermal or acid denaturation.
3.3. Maturation Site-Cleaved Pentamers and Wild-Type Pentamers Are Recognised Similarly by
Anti-FMDV
The sedimentation analysis above demonstrated that VP0-cleaved mat pentamers
were structurally different to wt pentamers. To determine whether this change in structure
affected the antigenic characteristics of the pentamers, a panel of anti-FMDV antibodies was
used to immunoprecipitate purified wt and VP0-cleaved mat pentamers. The antibodies
used and their reactivities are listed in Table 1.
Table 1. List of antibodies.
Antibody Description Reactivity Reference
Guniea pig (GP)
α-O1M
Reference sera from
Pirbright FMD World
Reference Laboratory
raised in guinea pigs
against FMDV
strain O1M
Whole virus capsid N/A
D9
Monoclonal antibody
raised against FMDV
type O
GH-loop of FMDV
type O VP1—linear
epitope
[38]
IB11
Monoclonal antibody
raised against FMDV
type O
Whole virus capsid—
conformational
epitope
[39]
Purified bovine
αVP2-N45
Antibodies specific
for the conserved
N-terminus of VP2
affinity purified from
FMDV α-SAT2 sera
VP2N45 Generated in thisstudy
Purified bovine
αVP4-N45
Antibodies specific
for the conserved
N-terminus of VP4
affinity purified from
FMDV α-SAT2 sera
VP4N45 Generated in thisstudy
VP4-specific antibodies, affinity purified from FMDV-infected bovine sera using a
peptide corresponding to the N-terminal 45 amino acids of VP4, were used to demonstrate
that the VP0 maturation cleavage had released VP4 from the mat pentamers. These VP4-
reactive antibodies efficiently immunoprecipitated wt pentamers but, in contrast, only
a minor proportion of VP0-cleaved mat pentamers were immunoprecipitated (Figure 4).
This was consistent with the predicted loss of the majority of VP4 after cleavage of mat
pentamers by Prepro and suggested that the VP0-cleaved mat pentamers were equivalent to
disassembly pentamers which lack VP4. VP2-specific antibodies were affinity purified in
the same way as for the VP4-speciific antibodies. These antibodies reacted equally well
with both wt and VP0-cleaved mat pentamers indicating that the VP0 cleavage and loss of
VP4 had not affected the binding of antibodies to VP2.
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Figure 4. FMDV mat mutant pentamers lack VP4 but are antigenically indistinguishable from wt
pentamers. Antibodies were incubated with either wt (red) and mat (orange) pentamers before the
addition of either Protein A (GP sera) or Protein G (all other antibodies) magnetic beads. Radioactivity
bound to the beads was read by scintillation counting. Pe tamer immunoprecipitation is expressed
as a proportion of input counts. The data shown re t e mean of two independent biological repeats
and error b r represent the range of the dat .
Polycl al sera against whole FMDV immunoprecipitated the wt and VP0-cleaved mat
pentamers equally well (Figure 4). A monoclonal antibody (D9) specific for the GH-loop
of FMDV, which includes a major immunogenic linear epitope, reacted equally with both
pentamers. A second monoclonal antibody, IB11, with an undefined conformational epitope
on the capsid also recognised both particles. Together, these data show that apart from the
expected reduction in reactivity of VP4-specific antibodies, both intact VP0 containing wt
pentamers and VP0-cleaved mat pentamers were recognised similarly by a number of virus
specific polyclonal and monoclonal antibodies.
4. Discussion
In this study, we have used a recombinant system for mimicking the maturation
cleavage in FMDV pentamers. We have shown that this introduced cleavage site can be
cleaved independently of the 3Cpro processing sites and that upon cleavage the pentamers
undergo a change in sedimentation. This change is consistent with a switch from the 14S
assembly pentamer described in most other picornaviruses [2,40] and the 12S disassembly
form of pentamer which is most often described in relation to FMDV. Historically, both
assembly and disassembly pentamers in FMDV are referred to as having a 12S sedimen-
tation in sucrose [28]. For FMDV, the 12S disassembly form of the pentamer is the easier
of the two forms to study and is also arguably more significant due to the implication of
disassembly for vaccines. Consequently, assembly pentamers have been overlooked and
both forms of FMDV pentamers have been indiscriminately labelled as 12S. In contrast,
other well-studied viruses in the enterovirus genus of the family do not disassemble and
remain as an intact capsid structure, meaning that only 14S assembly pentamers have been
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available for characterisation [2,41]. Therefore, the current study reconciles the capsid
assembly of FMDV with other picornaviruses.
The data presented here suggest that the loss of VP4 from disassembly pentamers
results in a less hydro-dynamically compact structure that sediments more slowly in
sucrose gradients relative to assembly pentamers. This also appears to be true of protomers
lacking VP4. The structure of pentamers dissociated from FMDV has been previously
determined [42] and in addition to lacking VP4, such disassembly pentamers appeared
structurally relaxed compared to pentamers observed in intact virions, with disordered VP1
and VP2 N-termini and a rotation in the VP3 protein resulting in a less compact structure
consistent with slower rate of sedimentation.
In existing structures of the FMDV virion, the VP4/2 site in VP0 is internal in the cap-
sid [15] and therefore inaccessible to external proteases, which has resulted in a hypothesis
that the cleavage involves an RNA-induced auto-catalytic event [11]. This however was not
true for the recombinant pentamers in the current study and Prepro, which is the 3Cpro from
HRV14, was able to access and cleave at this site. This suggests that the VP4/2 junction
of VP0 in wt pentamers is exposed to the cellular environment and has the potential to be
cleaved. The mechanism of maturation cleavage in FMDV is inferred from studies with
poliovirus where the RNA has an autocatalytic role upon encapsidation but the presence of
FMDV empty capsids with cleaved VP0 [13,14] suggests a different mechanism in FMDV
and that perhaps the accessibility of this site makes it vulnerable to cleavage. The PrePro
(3Cpro) recognition sequence in enteroviruses rarely varies at the P1/P1′ position; being a
Q/G pair [36]. Some FMDV cleavage junctions are also Q/G pairs but FMDV 3Cpro is more
tolerant in all positions (P4 to P4′) [32,34,41,43] around the cleavage junction. Therefore, it
seems unusual that FMDV 3Cpro cannot cleave this site in the mat pentamers and this may
warrant further investigation of cleavage site specificity.
We also showed that the 12S form of pentamer had a reduced reactivity with anti-VP4
antibodies after VP0 cleavage, consistent with loss of VP4 from the pentamer. Despite
a measurable change in conformation of the pentamer and apparent loss of VP4 upon
cleavage of VP0, the overall reactivity of the pentamer with other antibodies was un-
changed, suggesting that the global antigenicity of assembly and disassembly pentamers
may remain similar.
Earlier studies showed that FMDV pentamers from the assembly pathway could
generate a protective immune response in animals in contrast to dissociated pentamers
which were not protective [28]. This suggested that the two forms of pentamer were
antigenically distinct. However, in the current study, we were not able to differentiate
between the antigenicity of the recombinant 14S assembly and 12S disassembly pentamers
when using a panel of monoclonal and polyclonal antibodies, with the only apparent
difference being the loss of reactivity with anti-VP4 antibodies. Although VP4 is an internal
capsid protein, it has been shown in other picornaviruses to be transiently externalised
in a process known as capsid breathing [44,45], so that antibodies raised against the VP4
protein of HRV and PV can neutralise these viruses [45–47]. It is therefore possible that
VP4 specific antibodies may also play a role in the response to FMDV. It should also be
noted that studies of pentamer antigenicity cannot include epitopes formed at the pentamer
interfaces of fully assembled capsids, such epitopes may also be important.
The work presented here demonstrates a recombinant system to investigate differences
in the properties of picornavirus capsid components before and after the maturation cleav-
age, which may be useful in further studies of capsid assembly and vaccine antigenicity.
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